{"id":"intermittent-insulin-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Weight gain"}]},"_chembl":{"chemblId":"CHEMBL1201631","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This approach alternates periods of insulin administration with insulin-free intervals, theoretically allowing pancreatic beta cells to recover function and reducing the development of insulin resistance. The intermittent dosing pattern may also lower the overall insulin requirement while maintaining adequate blood glucose control in diabetic patients.","oneSentence":"Intermittent insulin therapy delivers insulin in periodic cycles rather than continuous infusion to improve glycemic control while potentially reducing hypoglycemia risk and insulin resistance.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:16:29.585Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT07378787","phase":"NA","title":"Time-Restricted Eating in Combination With a Low Glycaemic Index Diet on Cognitive Function, Biological Ageing and Metabolic Health in Perimenopause and Menopause.","status":"RECRUITING","sponsor":"University of Nicosia","startDate":"2026-01-17","conditions":"Late-perimenopause, Menopause, Perimenopause","enrollment":72},{"nctId":"NCT07088549","phase":"NA","title":"Intermittent Versus Continuous Glucose Monitoring in Intensive Care Unit","status":"NOT_YET_RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2025-07","conditions":"Critical Illness, Hyperglycaemia, Hypoglycaemia","enrollment":200},{"nctId":"NCT03305549","phase":"NA","title":"Recovery After Dialysis-Requiring Acute Kidney Injury","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2017-09-29","conditions":"Acute Kidney Injury","enrollment":16},{"nctId":"NCT06882291","phase":"NA","title":"Intermittent Fasting Diet Versus Resistive Exercise Program on Insulin Resistance in Obese Women With P.C.O.S","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-03-20","conditions":"Polycystic Ovary Syndrome","enrollment":72},{"nctId":"NCT06804044","phase":"NA","title":"Intermittent Fasting (IF) Has Gained Recognition as a Promising Weight Loss Approach That Improves Body Weight, Insulin Resistance, and Metabolism. While Standard Diets Are Common in PCOS Management, IF May Address the Underlying Causes of Weight Gain and Offer Additional Metabolic Benefits","status":"COMPLETED","sponsor":"Bahçeşehir University","startDate":"2022-11-30","conditions":"Polycystic Ovary Syndrome, Weight Loss, Intermittent Fasting","enrollment":33},{"nctId":"NCT06137963","phase":"NA","title":"Digital Diabetes Prevention Program Study","status":"WITHDRAWN","sponsor":"Hospital for Special Surgery, New York","startDate":"2024-01-24","conditions":"PreDiabetes","enrollment":""},{"nctId":"NCT05760339","phase":"NA","title":"Intermittent Fasting Versus Carbohydrate Drinks Before Surgery","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2023-03-20","conditions":"Perioperative Care, Intermittent Fasting, Carbohydrate Loading","enrollment":75},{"nctId":"NCT02498002","phase":"NA","title":"Impacts of Intermittent Fasting on Energy Balance and Associated Health Outcomes","status":"COMPLETED","sponsor":"University of Bath","startDate":"2015-05","conditions":"Obesity, Type 2 Diabetes","enrollment":54},{"nctId":"NCT04558827","phase":"NA","title":"Low-Carb/Time-restricted Feeding Protocol in Insulin-Using Type 2 Diabetics","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2021-02-01","conditions":"Type2 Diabetes","enrollment":20},{"nctId":"NCT04758858","phase":"NA","title":"Carbohydrates Under Target for Type 1 Diabetes Management","status":"WITHDRAWN","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2021-03","conditions":"Type 1 Diabetes","enrollment":""},{"nctId":"NCT04146155","phase":"PHASE4","title":"Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-05-01","conditions":"Type 2 Diabetes, Peripheral Vascular Disorder Due to Diabetes Mellitus","enrollment":200},{"nctId":"NCT02973438","phase":"NA","title":"Effects of Intermittent Hypoxia (IH) on Metabolism and Dysglycemia, in Overweight/Obese Persons SCI","status":"COMPLETED","sponsor":"University of Miami","startDate":"2016-12","conditions":"Spinal Cord Injuries, Obesity, Insulin Resistance","enrollment":6},{"nctId":"NCT02192424","phase":"PHASE3","title":"Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2014-07","conditions":"Type 2 Diabetes","enrollment":109},{"nctId":"NCT02703324","phase":"PHASE1","title":"A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2016-03","conditions":"Diabetes Mellitus, Type 1","enrollment":30},{"nctId":"NCT03056456","phase":"PHASE1","title":"A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2017-02-23","conditions":"Diabetes Mellitus, Type 1","enrollment":24},{"nctId":"NCT04141111","phase":"NA","title":"Retrospective and Prospective Study on Professional Continuous Glucose Monitoring in Insulin-treated Type 2 Diabetes","status":"COMPLETED","sponsor":"Associacao Protectora dos Diabeticos de Portugal","startDate":"2015-03-22","conditions":"Diabetes Mellitus, Type 2","enrollment":102},{"nctId":"NCT02853799","phase":"NA","title":"Comparison of the Effects of Intermittent and Continuous Enteral Feeding on Glucose-Insulin Dynamics in Critically Ill Medical Patients","status":"COMPLETED","sponsor":"San Antonio Military Medical Center","startDate":"2016-08","conditions":"Glucose-insulin Dynamics","enrollment":26},{"nctId":"NCT01755468","phase":"PHASE3","title":"Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2013-04","conditions":"Type 2 Diabetes","enrollment":24},{"nctId":"NCT02623478","phase":"PHASE1","title":"A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps","status":"WITHDRAWN","sponsor":"Eli Lilly and Company","startDate":"2018-01","conditions":"Diabetes Mellitus, Type 1","enrollment":""},{"nctId":"NCT03047824","phase":"NA","title":"Effects of GlucoClear CGM System on the Performance of Insulin Therapy in Critically Ill Patients","status":"COMPLETED","sponsor":"Erasme University Hospital","startDate":"2014-05","conditions":"Metabolic Stress Hyperglycemia","enrollment":100},{"nctId":"NCT02068638","phase":"NA","title":"Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2014-02","conditions":"Type 1 Diabetes Mellitus, Exercise, Hypoglycemia","enrollment":27},{"nctId":"NCT01799057","phase":"PHASE4","title":"The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication","status":"TERMINATED","sponsor":"Baker Heart and Diabetes Institute","startDate":"2013-07","conditions":"Peripheral Arterial Disease, Intermittent Claudication","enrollment":2},{"nctId":"NCT00177892","phase":"NA","title":"Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress","status":"UNKNOWN","sponsor":"National Institute on Aging (NIA)","startDate":"2003-09","conditions":"Obstructive Sleep Apnea, Metabolic Syndrome X","enrollment":76},{"nctId":"NCT00594152","phase":"PHASE3","title":"Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)","status":"COMPLETED","sponsor":"Joslin Diabetes Center","startDate":"1993-01","conditions":"Diabetic Nephropathy, Diabetic Retinopathy","enrollment":71},{"nctId":"NCT00410852","phase":"NA","title":"Efficacy and Safety of Three Insulin Protocols in Medical Intensive Care Unit Patients","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2005-05","conditions":"Intensive Care","enrollment":168}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":12,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Basal insulin glargine and pre-meal insulin lispro"],"phase":"phase_3","status":"active","brandName":"Intermittent insulin therapy","genericName":"Intermittent insulin therapy","companyName":"Mount Sinai Hospital, Canada","companyId":"mount-sinai-hospital-canada","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Intermittent insulin therapy delivers insulin in periodic cycles rather than continuous infusion to improve glycemic control while potentially reducing hypoglycemia risk and insulin resistance. Used for Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}